Adverum Biotechnologies Provides Program Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Adverum Biotechnologies (ADVM) PT Lowered to $4.50 at Chardan Capital Markets
November 2, 2018 9:05 AM EDTChardan Capital Markets analyst Gbola Amusa lowered the price target on Adverum Biotechnologies (NASDAQ: ADVM) to $4.50 (from $8.00) while maintaining a Neutral rating.
... MoreSunTrust Robinson Humphrey Downgrades Adverum Biotechnologies (ADVM) to Hold
November 2, 2018 6:23 AM EDTSunTrust Robinson Humphrey analyst Edward Nash downgraded Adverum Biotechnologies (NASDAQ: ADVM) from Buy to Hold with a price target of $4.00 (from $11.00).
Nash said they were surprised ADVM-043 is being discontinued due to lack of efficacy. Further, he highlights the company's second gene... More
